Ibuprofene B. Braun

Ibuprofen, the active ingredient in Ibuprofene B. Braun, is a nonsteroidal anti‑inflammatory drug presented as an intravenous solution for intravenous use. It is indicated for postoperative pain, fever, and various inflammatory conditions, providing rapid analgesic and antipyretic effects after intravenous administration in adult patients.

GNH USA supplies Ibuprofene B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The product conforms to EU quality standards and is manufactured under strict GMP conditions.

Ibuprofen, a nonsteroidal anti‑inflammatory drug, is indicated for conditions involving pain, fever, or inflammation.

- Mild to moderate pain: provides analgesic relief in adult patients - Post‑operative pain: reduces discomfort following surgical procedures - Fever: lowers elevated body temperature - Inflammatory conditions: decreases swelling and inflammatory response

Intravenous ibuprofen may be associated with a range of adverse reactions, varying from common, mild events to rare but serious conditions.

Common Side Effects: - Nausea: mild gastrointestinal upset after infusion - Dyspepsia: discomfort or burning in the upper abdomen - Headache: transient cranial pain during or after administration - Injection site reactions: erythema, pain, or swelling at the IV site - Dizziness: temporary light‑headedness or vertigo

Serious or Rare Side Effects: - Gastrointestinal bleeding: severe hemorrhage requiring medical attention - Renal impairment: acute kidney injury, especially in volume‑depleted patients - Severe allergic reactions: anaphylaxis, angioedema, or bronchospasm - Stevens‑Johnson syndrome/toxic epidermal necrolysis: rare life‑threatening skin reactions - Hepatic dysfunction: elevated liver enzymes or hepatitis - Thrombocytopenia: marked reduction in platelet count

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

- Assess renal function: evaluate baseline kidney status and avoid use in severe impairment - Monitor gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding - Check cardiovascular status: use cautiously in hypertension, heart failure, or coronary artery disease - Avoid concurrent NSAIDs: combined use increases risk of toxicity and bleeding - Pregnancy and lactation: limit use to situations where benefits outweigh potential risks - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake

Ibuprofene B. Braun can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and renal toxicity - ACE inhibitors or ARBs in dehydrated patients: increased risk of acute kidney injury

Moderate Interactions (Monitor Closely): - Corticosteroids: synergistic increase in gastrointestinal ulceration - Lithium: ibuprofen may raise serum lithium concentrations - Methotrexate: reduced clearance leading to potential toxicity